Mediendo, s.r.o.

Prague 18600

0 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease — Completed